Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.18632/oncotarget.19804

Título: Glioblastoma progression is assisted by induction of immunosuppressive function of pericytes through interaction with tumor cells
Fecha de publicación: 2-ago-2017
Editorial: Impact Journals
Cita bibliográfica: Oncotarget, 2017, Vol. 8, pp. 68614-68626
ISSN: Electronic: 1949-2553
Palabras clave: Glioblastoma multiforme
Brain perivascular cells
Tumor
Immunotolerance
T cells
Resumen: The establishment of immune tolerance during Glioblastoma Multiforme (GBM) progression, is characterized by high levels expression of anti-inflammatory cytokines, which suppress the function of tumor assocciated myeloid cells, and the activation and expansion of tumor antigen specific T cells. However, the mechanisms underlying the failed anti-tumor immune response around the blood vessels during GBM, are poorly understood. The consequences of possible interactions between cancer cells and the perivascular compartment might affect the tumor growth. In this work we show for the first time that GBM cells induce immunomodulatory changes in pericytes in a cell interaction-dependent manner, acquiring an immunosuppresive function that possibly assists the evasion of the anti-tumor immune response and consequently participates in tumor growth promotion. Expression of high levels of anti-inflammatory cytokines was detected in vitro and in vivo in brain pericytes that interacted with GBM cells (GBC-PC). Furthermore, reduction of surface expression of co-stimulatory molecules and major histocompatibility complex molecules in GBC-PC correlated with a failure of antigen presentation to T cells and the acquisition of the ability to supress T cell responses. In vivo, orthotopic xenotransplant of human glioblastoma in an immunocompetent mouse model showed significant GBM cell proliferation and tumor growth after the establishment of interspecific immunotolerance that followed GMB interaction with pericytes.
Autor/es principal/es: Valdor, Rut
García Bernal, David
Bueno, Carlos
Ródenas, Mónica
Moraleda, José M.
Macián, Fernando
Martínez, Salvador
Versión del editor: https://www.oncotarget.com/article/19804/
URI: http://hdl.handle.net/10201/148691
DOI: https://doi.org/10.18632/oncotarget.19804
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 13
Derechos: info:eu-repo/semantics/openAccess
Atribución 4.0 Internacional
Descripción: © Valdor et al. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This document is the Published Manuscript version of a Published Work that appeared in final form in Oncotarget. To access the final edited and published work see https://doi.org/10.18632/oncotarget.19804
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
oncotarget-v8i40-19804.pdf3,05 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons